Burney Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Sell |
9,523
-3,980
| -29% | -$500K | 0.04% | 292 |
|
|
2025
Q1 | $1.49M | Sell |
13,503
-13,849
| -51% | -$1.53M | 0.05% | 257 |
|
|
2024
Q4 | $3.73M | Sell |
27,352
-99,173
| -78% | -$13.5M | 0.13% | 158 |
|
|
2024
Q3 | $14.6M | Buy |
126,525
+43,947
| +53% | +$5.06M | 0.52% | 50 |
|
|
2024
Q2 | $11.4M | Buy |
82,578
+3,236
| +4% | +$446K | 0.43% | 62 |
|
|
2024
Q1 | $10.9M | Sell |
79,342
-8,895
| -10% | -$1.23M | 0.42% | 59 |
|
|
2023
Q4 | $11.6M | Buy |
88,237
+14,990
| +20% | +$1.98M | 0.49% | 49 |
|
|
2023
Q3 | $8.24M | Buy |
73,247
+33,045
| +82% | +$3.72M | 0.39% | 67 |
|
|
2023
Q2 | $3.79M | Buy |
40,202
+20,238
| +101% | +$1.91M | 0.17% | 154 |
|
|
2023
Q1 | $2.02M | Buy |
19,964
+3,332
| +20% | +$337K | 0.1% | 221 |
|
|
2022
Q4 | $1.99M | Buy |
+16,632
| New | +$1.99M | 0.1% | 202 |
|